Group One Trading’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Group One Trading’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,385	Closed	-$73.1K	–	8785
2021 Q1	$61K	Buy	+2,385	New	+$60.9K	﹤0.01%	6084
2020 Q4	–	Sell	-61,691	Closed	-$1.36M	–	7243
2020 Q3	$1.11M	Buy	+61,691	New	+$1.28M	﹤0.01%	2095
2017 Q4	–	Sell	-5,000	Closed	-$36.8K	–	5395
2017 Q3	$29K	Buy	+5,000	New	+$18.2K	﹤0.01%	3900

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Group One Trading's DRNA Position: Q2 2021 in Review

Group One Trading sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2021, closing a stake of 2,385 shares — an estimated $73.1K sold.

Group One Trading first reported a position in DRNA in Q3 2017 and held it in 3 quarters. The position peaked at $1.11M in Q3 2020. 203 funds tracked by Wall St. Rank hold DRNA as of Q2 2021.

Group One Trading reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Group One Trading sold 2,385 Dicerna Pharmaceuticals, Inc. shares in Q2 2021, an estimated $73.1K.
Group One Trading first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2017 and held it in 3 quarters.
Group One Trading's Dicerna Pharmaceuticals, Inc. position peaked at $1.11M in Q3 2020.
203 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2021.

Based on Group One Trading's 13F filing for Q2 2021, filed 10 Aug 2021.